随机对照试验评估日常认知训练对乳腺癌患者治疗相关认知损害的影响
Effects of a cognitive training program on cancer-related cognitive impairment in breast cancer patients in active treatment: a randomized controlled trial
一项随机对照试验显示,在乳腺癌活动治疗期进行为期4个月的日常认知训练,显著改善了患者自我感知的认知能力(FACT-Cog PCA域,p<0.001)。然而,该干预未对客观认知功能(MoCA)、焦虑、睡眠质量及日常功能等指标产生统计学显著的组间差异。
Abstract
Cancer-related cognitive impairment (CRCI) is a frequent and distressing complication in women undergoing active treatment for breast cancer. Although cognitive training has shown promise as a non-pharmacological strategy, evidence on ecologically valid interventions during active treatment remains limited. To evaluate the efficacy of an everyday cognition-based training program on cognitive function and related psychological and functional outcomes in women with breast cancer receiving active treatment. In this randomized controlled trial, 50 women newly diagnosed with breast cancer (within 6 months) were allocated (1:1) to either an Intervention Group (n = 25; receiving a 4-month structured home-based daily cognitive training program of 80 real-life activities plus Health Education) or a Control Group (n = 25; receiving Health Education alone). The control group received a health education program. Co-primary outcomes were objective cognitive performance (MoCA) and subjective cognitive function (FACT-Cog). Secondary outcomes included everyday cognition (PECC), anxiety (Hamilton scale), sleep quality (PSQI), functional independence (Lawton & Brody), performance status (ECOG), and subjective memory complaints (MFF). Assessments were conducted at baseline and post-intervention (4 months). After adjusting for baseline scores using ANCOVA, the intervention group demonstrated a statistically significant improvement in perceived cognitive abilities (FACT-Cog PCA domain; \(\:F=24.60\), \(\:p<0.001\), \(\:{\eta\:}_{p}^{2}=0.35\)) compared to the control group. In contrast, no significant between-group differences were observed for objective global cognitive performance (MoCA; \(\:F=0.03\), \(\:p=0.856\)) or other FACT-Cog subscales. Everyday cognition (PECC) showed a positive unadjusted trend (\(\:p=0.066\), \(\:d=0.57\)), which did not remain statistically significant in baseline-adjusted models (\(\:p=0.614\)). No significant intervention effects were detected for anxiety, sleep quality, functional independence, performance status, or subjective memory complaints after baseline adjustment. A structured everyday cognition-based training program improves perceived cognitive abilities during active breast cancer treatment. However, no significant effects were confirmed for objective cognitive screening scores or general functional outcomes.
Acknowledgements
The authors have nothing to report.
Funding
No funding was received to carry out this study.
Author information
Authors and Affiliations
Faculty of Medicine, Department of Medicine, University of Salamanca, Salamanca, 37007, Spain
Juan Luis Sánchez-González & Jesús Pérez
Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
Juan Luis Sánchez-González, Celia Sánchez-Gómez, Emilio Fonseca-Sánchez, Nuria Arroyo-Garrapucho, Jesús Pérez & Eduardo José Fernández-Rodríguez
Doctoral Program in Health, Disability, Dependency and Well-being, University of Salamanca, Salamanca, Spain
Samuel Jiménez-Sánchez
Faculty of Psychology, Department of Developmental and Educational Psychology, University of Salamanca, Salamanca, Spain
Celia Sánchez-Gómez & Sara Jiménez García-Tizón
Department of Medical Oncology, University Hospital of Salamanca, Salamanca, 37007, Spain
Emilio Fonseca-Sánchez
Faculty of Medicine, Department of Statistics, University of Salamanca, Salamanca, Spain
Nuria Arroyo-Garrapucho
Cambridgeshire and Peterborough NHS Foundation Trust, Reino Unido, Cambridge, CB215EF, UK
Jesús Pérez
Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK
Jesús Pérez
School of Occupational Therapy, Faculty of Psychology, University of Talca, Talca, 3465548, Chile
Edgar Vaszquez-Carrasco
Department of Nursing and Physiotherapy, University of Salamanca, Salamanca, Spain
Eduardo José Fernández-Rodríguez
Authors
- Juan Luis Sánchez-González
- Samuel Jiménez-Sánchez
- Celia Sánchez-Gómez
- Emilio Fonseca-Sánchez
- Nuria Arroyo-Garrapucho
- Jesús Pérez
- Edgar Vaszquez-Carrasco
- Sara Jiménez García-Tizón
- Eduardo José Fernández-Rodríguez
Corresponding author
Correspondence to Celia Sánchez-Gómez.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
was obtained from the Ethics Committee in Drug Research of the Salamanca Health Area (Code of Ethics: CEIm PI 2023 12 1478—TD). The trial was prospectively registered at ClinicalTrials.gov (NCT06686823; registration date: November 11, 2024). All experimental protocols and methods were performed in accordance with relevant institutional guidelines and regulations, including the Declaration of Helsinki and CONSORT guidelines. Informed consent was obtained from all participants prior to study inclusion.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Sánchez-González, J.L., Jiménez-Sánchez, S., Sánchez-Gómez, C. et al. Effects of a cognitive training program on cancer-related cognitive impairment in breast cancer patients in active treatment: a randomized controlled trial. Sci Rep (2026). https://doi.org/10.1038/s41598-026-76536-3
Received: 21 April 2026
Accepted: 14 October 2026
Published: 23 October 2026
DOI: https://doi.org/10.1038/s41598-026-76536-3
Keywords
来源:Nature 健康护理主题 · nature.com